These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17931639)

  • 21. Cyclodextrins as functional excipients: methods to enhance complexation efficiency.
    Loftsson T; Brewster ME
    J Pharm Sci; 2012 Sep; 101(9):3019-32. PubMed ID: 22334484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PCA-CR analysis of dissolution profiles. A chemometric approach to probe the polymorphic form of the active pharmaceutical ingredient in a drug product.
    Maggio RM; Castellano PM; Kaufman TS
    Int J Pharm; 2009 Aug; 378(1-2):187-93. PubMed ID: 19477254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-processing of hydroxypropyl methylcellulose (HPMC) for improved aqueous dispersibility.
    Sharma P; Modi SR; Bansal AK
    Int J Pharm; 2015 May; 485(1-2):348-56. PubMed ID: 25796127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of COSMO-RS as an excipient ranking tool in early formulation development.
    Pozarska A; da Costa Mathews C; Wong M; Pencheva K
    Eur J Pharm Sci; 2013 Jul; 49(4):505-11. PubMed ID: 23639717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical assessment of inverse gas chromatography as means of assessing surface free energy and acid-base interaction of pharmaceutical powders.
    Telko MJ; Hickey AJ
    J Pharm Sci; 2007 Oct; 96(10):2647-54. PubMed ID: 17518355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multivariate raw material property database to facilitate drug product development and enable in-silico design of pharmaceutical dry powder processes.
    Van Snick B; Dhondt J; Pandelaere K; Bertels J; Mertens R; Klingeleers D; Di Pretoro G; Remon JP; Vervaet C; De Beer T; Vanhoorne V
    Int J Pharm; 2018 Oct; 549(1-2):415-435. PubMed ID: 30118831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of partial solubility parameters of lactose by gas-solid chromatography.
    Nguyen HP; Luu RP; Munafo A; Ruelle P; Ho NT; Buchmann M; Kesselring UW
    J Pharm Sci; 1986 Jan; 75(1):68-72. PubMed ID: 3958909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new method to determine the partial solubility parameters of polymers from intrinsic viscosity.
    Bustamante P; Navarro-Lupión J; Escalera B
    Eur J Pharm Sci; 2005 Feb; 24(2-3):229-37. PubMed ID: 15661495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a partially automated solubility screening (PASS) assay for early drug development.
    Alsenz J; Meister E; Haenel E
    J Pharm Sci; 2007 Jul; 96(7):1748-62. PubMed ID: 17238197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Theoretical analysis of release kinetics of coated tablets containing constant and non-constant drug reservoirs.
    Zhou Y; Chu JS; Li JX; Wu XY
    Int J Pharm; 2010 Jan; 385(1-2):98-103. PubMed ID: 19879936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developing early formulations: practice and perspective.
    Li P; Zhao L
    Int J Pharm; 2007 Aug; 341(1-2):1-19. PubMed ID: 17658228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physicochemical characterization of D-mannitol polymorphs: the challenging surface energy determination by inverse gas chromatography in the infinite dilution region.
    Cares-Pacheco MG; Vaca-Medina G; Calvet R; Espitalier F; Letourneau JJ; Rouilly A; Rodier E
    Int J Pharm; 2014 Nov; 475(1-2):69-81. PubMed ID: 25151549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of excipients on solubility and dissolution of pharmaceuticals.
    Paus R; Prudic A; Ji Y
    Int J Pharm; 2015 May; 485(1-2):277-87. PubMed ID: 25749073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expanded solubility parameter approach. I: Naphthalene and benzoic acid in individual solvents.
    Beerbower A; Wu PL; Martin A
    J Pharm Sci; 1984 Feb; 73(2):179-88. PubMed ID: 6707879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Practical considerations in development of solid dosage forms that contain cyclodextrin.
    Miller LA; Carrier RL; Ahmed I
    J Pharm Sci; 2007 Jul; 96(7):1691-707. PubMed ID: 17243148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmaceutical spray freeze drying.
    Wanning S; Süverkrüp R; Lamprecht A
    Int J Pharm; 2015 Jul; 488(1-2):136-53. PubMed ID: 25900097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excipient variability and its impact on dosage form functionality.
    Dave VS; Saoji SD; Raut NA; Haware RV
    J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perspective on improving passive human intestinal absorption.
    Yalkowsky SH
    J Pharm Sci; 2012 Sep; 101(9):3047-50. PubMed ID: 22374839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Towards a rational basis for selection of excipients: Excipient Efficiency for controlled release.
    Casas M; Aguilar-de-Leyva Á; Caraballo I
    Int J Pharm; 2015 Oct; 494(1):288-95. PubMed ID: 26253376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highly loaded interactive mixtures for dry powder inhalers: prediction of the adhesion capacity using surface energy and solubility parameters.
    Wagner KG; Dowe U; Zadnik J
    Pharmazie; 2005 May; 60(5):339-44. PubMed ID: 15918581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.